TY - JOUR
T1 - Menstrual cycle and oral contraceptive use do not modify postexercise heat loss responses
AU - Kenny, Glen P.
AU - Leclair, Emily
AU - Sigal, Ronald J.
AU - Journeay, W. Shane
AU - Kilby, Donald
AU - Nettlefold, Lindsay
AU - Reardon, Francis D.
AU - Jay, Ollie
PY - 2008/10
Y1 - 2008/10
N2 - It is unknown whether menstrual cycle or oral contraceptive (OC) use influences nonthermal control of postexercise heat loss responses. We evaluated the effect of menstrual cycle and OC use on the activation of heat loss responses during a passive heating protocol performed pre- and postexercise. Women without OC (n = 8) underwent pre- and postexercise passive heating during the early follicular phase (FP) and midluteal phase (LP). Women with OC (n = 8) underwent testing during the active pill consumption (high exogenous hormone phase, HH) and placebo (low exogenous hormone phase, LH) weeks. After a 60-min habituation at 26°C, subjects donned a liquid conditioned suit. Mean skin temperature was clamped at ∼32.5°C for ∼15 min and then gradually increased, and the absolute esophageal temperature at which the onset of forearm vasodilation (ThVD) and upper back sweating (ThSW) were noted. Subjects then cycled for 30 min at 75% V̇O2 peak followed by a 15-min seated recovery. A second passive heating was then performed to establish postexercise values for ThVD and ThSW. Between 2 and 15 min postexercise, mean arterial pressure (MAP) remained significantly below baseline (P < 0.05) by 10 ± 1 and 11 ± 1 mmHg for the FP/LH and LP/HH, respectively. MAP was not different between cycle phases. During LP/HH, ThVD was 0.16 ± 0.24°C greater than FP/LH preexercise (P = 0.020) and 0.15 ± 0.23°C greater than FP/LH postexercise (P = 0.017). During LP/HH, ThSW was 0.17 ± 0.23°C greater than FP/LH preexercise (P = 0.016) and 0.18 ± 0.16°C greater than FP/LH postexercise (P = 0.001). Postexercise thresholds were significantly greater (P ≤ 0.001) than preexercise during both FP/LH (ThVD, 0.22 ± 0.03°C; ThSW, 0.13 ± 0.03°C) and LP/HH (Th VD, 0.21 ± 0.03°C; ThSW, 0.14 ± 0.03°C); however, the effect of exercise was similar between LP/HH and FP/LH. No effect of OC use was observed. We conclude that neither menstrual cycle nor OC use modifies the magnitude of the postexercise elevation in Th VD and ThSW.
AB - It is unknown whether menstrual cycle or oral contraceptive (OC) use influences nonthermal control of postexercise heat loss responses. We evaluated the effect of menstrual cycle and OC use on the activation of heat loss responses during a passive heating protocol performed pre- and postexercise. Women without OC (n = 8) underwent pre- and postexercise passive heating during the early follicular phase (FP) and midluteal phase (LP). Women with OC (n = 8) underwent testing during the active pill consumption (high exogenous hormone phase, HH) and placebo (low exogenous hormone phase, LH) weeks. After a 60-min habituation at 26°C, subjects donned a liquid conditioned suit. Mean skin temperature was clamped at ∼32.5°C for ∼15 min and then gradually increased, and the absolute esophageal temperature at which the onset of forearm vasodilation (ThVD) and upper back sweating (ThSW) were noted. Subjects then cycled for 30 min at 75% V̇O2 peak followed by a 15-min seated recovery. A second passive heating was then performed to establish postexercise values for ThVD and ThSW. Between 2 and 15 min postexercise, mean arterial pressure (MAP) remained significantly below baseline (P < 0.05) by 10 ± 1 and 11 ± 1 mmHg for the FP/LH and LP/HH, respectively. MAP was not different between cycle phases. During LP/HH, ThVD was 0.16 ± 0.24°C greater than FP/LH preexercise (P = 0.020) and 0.15 ± 0.23°C greater than FP/LH postexercise (P = 0.017). During LP/HH, ThSW was 0.17 ± 0.23°C greater than FP/LH preexercise (P = 0.016) and 0.18 ± 0.16°C greater than FP/LH postexercise (P = 0.001). Postexercise thresholds were significantly greater (P ≤ 0.001) than preexercise during both FP/LH (ThVD, 0.22 ± 0.03°C; ThSW, 0.13 ± 0.03°C) and LP/HH (Th VD, 0.21 ± 0.03°C; ThSW, 0.14 ± 0.03°C); however, the effect of exercise was similar between LP/HH and FP/LH. No effect of OC use was observed. We conclude that neither menstrual cycle nor OC use modifies the magnitude of the postexercise elevation in Th VD and ThSW.
UR - http://www.scopus.com/inward/record.url?scp=55449113082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55449113082&partnerID=8YFLogxK
U2 - 10.1152/japplphysiol.00194.2008
DO - 10.1152/japplphysiol.00194.2008
M3 - Article
C2 - 18687980
AN - SCOPUS:55449113082
SN - 8750-7587
VL - 105
SP - 1156
EP - 1165
JO - Journal of Applied Physiology
JF - Journal of Applied Physiology
IS - 4
ER -